Emission from Human Skin in the Sub THz Frequency Band

Recently published Radiometric measurements of human subjects in the frequency range 480-700 GHz, demonstrate the emission of blackbody radiation from the body core, rather than the skin surface. We present a detailed electromagnetic simulation of the dermis and epidermis, taking into account the presence of the sweat duct. This complex structure can be considered as an electromagnetic bio-metamaterial, whereby the layered structure, along with the topology of the sweat duct, reveals a complex interference pattern in the skin. The model is capable of accurately representing the skin greyness factor as a function of frequency and this is confirmed by radiometry of living human skin.

A case report of generalised eruptive syringoma: a rare variant of syringoma

<p class="abstract">Syringomas are benign adnexal neoplasm of eccrine sweat duct usually affecting adult women. They present as firm, skin coloured to yellowish papules in a symmetrical distribution over periorbital region. Eruptive syringomas are infrequent and usually appear at uncommon sites. Herein, we report a case of a 21-year old girl with eruptive syringomas with an extensive involvement.</p>

Cetuximab Induced Hidrocystomas: A Case Report

Cetuximab is an epidermal growth factor receptor (EGFR) inhibitor that commonly results in follicular-based acneiform eruptions. EGFR is expressed in the epidermis, hair follicle epithelium, sweat gland apparatus, and plays an important role in the differentiation and development of the hair follicle. In this report we describe a 70-year-old man who developed an acneiform eruption on his nose, cheeks, neck, and back when cetuximab was started for metastatic colorectal carcinoma. This initial eruption improved with cessation of cetuximab but left residual cystic papules on his nose and multiple superficial white cysts on his bilateral cheeks, neck and back. Skin biopsy of a representative lesion on the nose revealed a cyst-like cavity lined with epithelium similar to sweat glands within the dermis consistent with a hidrocystoma. In this case, it is plausible that the use of an EGFR inhibitor resulted in a cutaneous inflammatory reaction, that subsequently healed with blockage of the sweat duct apparatus causing the formation of cutaneous cysts, including both hidrocystomas and milia. Alternatively, the blockage of the duct may have resulted from inhibition of basal cell migration and increased cell adhesion within the eccrine gland causing accumulation of eccrine gland secretion, and eventually hidrocystomas. To our knowledge, this is the first case describing the resolution of a typical cetuximab-induced acneiform eruption with residual hidrocystomas and milia.